{"id":"W2315566794","doi":"10.1200/jco.2015.33.15_suppl.8100","title":"Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Afatinib; Lung cancer; Erlotinib; Chemotherapy; Gastroenterology; Surgery; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001827093,0.0006955151,0.001426842,0.000351812,0.0002230592,0.0009215324,0.0005711896,0.00117504,0.004652075],"category_scores_gemma":[0.001908613,0.000259445,0.001791698,0.0003481987,0.0003711063,0.001134335,0.0003324955,0.002115126,0.0005729874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006275385,"about_ca_system_score_gemma":0.0006305177,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007344608,"about_ca_topic_score_gemma":0.002147406,"domain_scores_codex":[0.9995414,0.0002421437,0.00004060873,0.00006435,0.00003415407,0.0000772852],"domain_scores_gemma":[0.9990467,0.0003321515,0.0002454114,0.00004780608,0.00003861731,0.0002892293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9366346,0.003253496,0.002502159,0.0009057689,0.00152414,0.00005898273,0.00006510878,0.001612899,0.002275438,0.0001950173,0.002260138,0.04871235],"study_design_scores_gemma":[0.7062231,0.2690368,0.01379363,0.0001788919,0.002393087,0.0003159625,0.0001216635,0.002995917,0.001226899,0.0007098527,0.002955144,0.00004913521],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845106,0.009061242,0.0002495787,0.00100493,0.0004987427,0.0005112112,0.001371543,0.00006514307,0.002726958],"genre_scores_gemma":[0.9942871,0.002077729,0.0002959779,0.0005475529,0.0001854924,0.0003851764,0.0007913577,0.000007991434,0.001421578],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004652075,"threshold_uncertainty_score":0.01556277,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1225624270088671,"score_gpt":0.466239959077495,"score_spread":0.3436775320686279,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}